Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 4/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 2/20 | 0.30 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20617380 | 0.97 | RXRA (0.36) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL19903660 | 0.95 | ALOX5AP (0.36) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL19903460 | 0.94 | STS (0.34) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL25660561 | 0.92 | ALOX5AP (0.39) | STSALOX5APFEN1ARKIF11 | |
| SCHEMBL20849577 | 0.92 | STS (0.34) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL20617381 | 0.92 | RXRA (0.39) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL20617384 | 0.91 | RXRA (0.36) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL19917948 | 0.91 | RXRA (0.31) | RXRARXRGARKIF11PTGER4 | |
| SCHEMBL20848863 | 0.91 | STS (0.33) | STSALOX5APFEN1RXRARXRG | |
| SCHEMBL20848569 | 0.90 | STS (0.36) | STSALOX5APFEN1RXRARXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-10-08 | — | — | US | disclosed |
| EP-3360945-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | CYNORA GMBH (DE) | 2019-04-24 | — | — | EP | disclosed |
| EP-3287450-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-03-20 | — | — | EP | disclosed |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| EP-3287450-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, ORC3, AOC3 | STS 1862/4885ALOX5AP 3371/4885FEN1 1443/4885 |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | STS 1632/4885ALOX5AP 3376/4885FEN1 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.